Compare TRMK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRMK | BHVN |
|---|---|---|
| Founded | 1889 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1994 | 2022 |
| Metric | TRMK | BHVN |
|---|---|---|
| Price | $44.52 | $11.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 17 |
| Target Price | ★ $50.50 | $21.27 |
| AVG Volume (30 Days) | 351.1K | ★ 2.4M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | 1.93 | ★ 26.08 |
| EPS | ★ 2.03 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.36 | N/A |
| Revenue Next Year | $6.20 | N/A |
| P/E Ratio | $21.79 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.33 | $7.48 |
| 52 Week High | $49.00 | $18.57 |
| Indicator | TRMK | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.25 | 37.25 |
| Support Level | $43.37 | $10.75 |
| Resistance Level | $45.48 | $12.03 |
| Average True Range (ATR) | 0.72 | 0.68 |
| MACD | -0.12 | -0.12 |
| Stochastic Oscillator | 23.42 | 9.02 |
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.